{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:31:56Z","timestamp":1777303916663,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,27]]},"DOI":"10.7759\/cureus.107807","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:32:08Z","timestamp":1777300328000},"source":"Crossref","is-referenced-by-count":0,"title":["Ceftriaxone-Induced Leukopenia During Inpatient Rehabilitation: A Case Report"],"prefix":"10.7759","author":[{"given":"Luis D","family":"Rivera-Amador","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean P","family":"Moliere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olu","family":"Oyesanmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwardo","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rigoberto","family":"Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Label. ceftriaxone injection, powder, for solution. (2024). Accessed: 2024: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=96f3fc1e-84f4-4e9b-91ac-19a1692f227a."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn F","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med. 2007, 146:657-65. 10.7326\/0003-4819-146-9-200705010-00009","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.187","article-title":"Non-chemotherapy drug-induced neutropenia: key points to manage the challenges","volume":"2017","author":"Curtis BR","year":"2017","unstructured":"Curtis BR. Non-chemotherapy drug-induced neutropenia: key points to manage the challenges. Hematology Am Soc Hematol Educ Program. 2017, 2017:187-93. 10.1182\/asheducation-2017.1.187","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/152.1.90","article-title":"Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics","volume":"152","author":"Neftel KA","year":"1985","unstructured":"Neftel KA, Hauser SP, M\u00fcller MR. Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics. J Infect Dis. 1985, 152:90-8. 10.1093\/infdis\/152.1.90","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12419","article-title":"Beta-lactam-induced severe neutropaenia: a descriptive study","volume":"33","author":"Vial T","year":"2019","unstructured":"Vial T, Bailly H, Perault-Pochat MC, Default A, Boulay C, Chouchana L, Kassai B. Beta-lactam-induced severe neutropaenia: a descriptive study. Fundam Clin Pharmacol. 2019, 33:225-31. 10.1111\/fcp.12419","journal-title":"Fundam Clin Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1060028020975646","article-title":"A review of \u03b2-lactam-associated neutropenia and implications for cross-reactivity","volume":"55","author":"Cimino C","year":"2021","unstructured":"Cimino C, Allos BM, Phillips EJ. A review of \u03b2-lactam-associated neutropenia and implications for cross-reactivity. Ann Pharmacother. 2021, 55:1037-49. 10.1177\/1060028020975646","journal-title":"Ann Pharmacother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2006.07.012","article-title":"Idiosyncratic drug-induced agranulocytosis: update of an old disorder","volume":"17","author":"Andr\u00e8s E","year":"2006","unstructured":"Andr\u00e8s E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F. Idiosyncratic drug-induced agranulocytosis: update of an old disorder. Eur J Intern Med. 2006, 17:529-35. 10.1016\/j.ejim.2006.07.012","journal-title":"Eur J Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.11.002","article-title":"8. Drug allergy","volume":"117","author":"Greenberger PA","year":"2006","unstructured":"Greenberger PA. 8. Drug allergy. J Allergy Clin Immunol. 2006, 117:S464-70. 10.1016\/j.jaci.2005.11.002","journal-title":"J Allergy Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.727717","article-title":"Drug-induced idiosyncratic agranulocytosis: infrequent but dangerous","volume":"12","author":"Rattay B","year":"2021","unstructured":"Rattay B, Benndorf RA. Drug-induced idiosyncratic agranulocytosis: infrequent but dangerous. Front Pharmacol. 2021, 12:727717. 10.3389\/fphar.2021.727717","journal-title":"Front Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.4.369","article-title":"A population-based case-cohort study of drug-associated agranulocytosis","volume":"159","author":"van der Klauw MM","year":"1999","unstructured":"van der Klauw MM, Goudsmit R, Halie MR, van't Veer MB, Herings RM, Wilson JH, Stricker BH. A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med. 1999, 159:369-74. 10.1001\/archinte.159.4.369","journal-title":"Arch Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15170","article-title":"Acute antibiotically induced neutropenia: a systematic review of case reports","volume":"88","author":"Holz JM","year":"2022","unstructured":"Holz JM, Chevtchenko AV, Aitullina A. Acute antibiotically induced neutropenia: a systematic review of case reports. Br J Clin Pharmacol. 2022, 88:1978-84. 10.1111\/bcp.15170","journal-title":"Br J Clin Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-013-1618-1","article-title":"Drug-induced agranulocytosis in the Berlin case-control surveillance study","volume":"70","author":"Huber M","year":"2014","unstructured":"Huber M, Andersohn F, Bronder E, et al.. Drug-induced agranulocytosis in the Berlin case-control surveillance study. Eur J Clin Pharmacol. 2014, 70:339-45. 10.1007\/s00228-013-1618-1","journal-title":"Eur J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/484946-ceftriaxone-induced-leukopenia-during-inpatient-rehabilitation-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:32:12Z","timestamp":1777300332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/484946-ceftriaxone-induced-leukopenia-during-inpatient-rehabilitation-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.107807","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}